Startups
ISPE
Edit

ISPE

Trusted
https://ispe.org/
Last activity: 01.09.2026
Active
Categories: BuildingCenterDeliveryDevelopmentEdTechEngineeringHardwareMedTechSocietyTraining
ISPE, the International Society for Pharmaceutical Engineering, is the world’s largest not-for-profit association serving its Members through leading scientific, technical and regulatory advancement throughout the entire pharmaceutical lifecycle. The 18,000 Members of ISPE are building solutions in the development and manufacture of safe and effective pharmaceutical and biologic medicines and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters in Bethesda, Maryland, USA and the Operations and Training Center in Tampa, Florida, USA.
Likes
4.06K
Followers
4.38K
Followers
39.57K
Website visits
121.3K /mo.
Mentions
69

Overview

Location
United States, Maryland, North Bethesda
Employees
201-500
Phone
+1 813-960-2105
Founded date
1980

Mentions in press and media 69

DateTitleDescription
Sign up to seeSign up to seeSign up to see
May 13, 2026Modicus Prime Secures $8 Million to Revolutionize Pharma AI ComplianceModicus Prime secured $8 million total funding, with a fresh $4.5 million infusion. This investment fuels its mission to provide robust AI compliance infrastructure for the pharmaceutical industry. The company's Trustworthy AI Compliance So...
May 8, 2026Modicus Prime: $8 Million Raised To Expand AI Compliance Infrastructure For PharmaModicus Prime announced it raised a total of $8 million in funding following an additional $4.5 million investment led by Frist Cressey Ventures, with participation from Silverton Partners and Oncology Ventures. The company said the financi...
Sep 4, 2025AI Governance as Competitive Capability: The Pioneering Work of Sumesh Nair in BiopharmaCreated by Carl Williams Published: Sep 04 2025, 00:41 AM EDT Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard
Aug 6, 2025Quantifying the ROI of Compliance: Sumesh Nair on Architecting Risk-Based AI Validation for Modern Clinical TrialsShare Share Share Share Email For any new therapy to reach the patients who need it, it must first navigate a formidable and complex global regulatory landscape. In the life sciences industry, this landscape is built upon a foundational set...
Apr 3, 202523andMe's Rocky Road: A Genetic Gamble in BankruptcyThe story of 23andMe is a tale of ambition, innovation, and now, a desperate scramble for survival. Once a beacon of hope in the consumer genetics landscape, the company has hit a wall. It filed for Chapter 11 bankruptcy protection, a move ...
Apr 2, 20252025 ISPE Europe Annual Conference Debuts New Workshops and Announces Keynote SpeakersThe 2025 ISPE Europe Annual Conference plans to have strong regulatory participation from European health authorities. The 2025 ISPE Europe Annual Conference will take place 12 – 14 May in London, United Kingdom (UK), and virtually. NORTH B...
Mar 26, 20252025 ISPE Biotechnology Conference Announces Keynote SpeakersThe 2025 ISPE Biotechnology Conference will feature speakers from throughout the biotech ecosystem. The 2025 ISPE Biotechnology Conference will take place 2 – 3 June in Boston, Massachusetts, USA, and virtually. NORTH BETHESDA, Md., March 2...
Sep 19, 20242024 ISPE Pharma 4.0™ and Annex 1 Conference Featured Speakers Are AnnouncedThe 2024 ISPE Pharma 4.0™ and Annex 1 Conference will take place on 10-11 December in Rome, Italy, and virtually. The 2024 ISPE Pharma 4.0™ and Annex 1 Conference will take place on 10-11 December in Rome, Italy, and virtually. NORTH BETHES...
Aug 27, 2024Currax Pharmaceuticals: CONTRAVE®/MYSIMBA® Demonstrates Positive Cardiovascular Safety in a Large, Real-World Evidence StudyBRENTWOOD, Tenn., Aug. 27, 2024 /PRNewswire/ -- Currax Pharmaceuticals LLC ("Currax") today announced the results of a Cardiovascular Health Outcomes Analysis (HOA). The results showed there is no evidence of excess cardiovascular...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In

FAQ about ISPE

When was ISPE founded?

ISPE was founded in 1980.

What has the press written about ISPE?

Parsers VC has collected 69 articles mentioning ISPE, among them “Modicus Prime Secures $8 Million to Revolutionize Pharma AI Compliance” (May 13, 2026) and “Modicus Prime: $8 Million Raised To Expand AI Compliance Infrastructure For Pharma” (May 8, 2026).

Is ISPE still active?

Yes, ISPE is active; its latest activity on Parsers VC dates from Sep 1, 2026.